Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript March 18, 2026 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.15768, expectations were $-0.18897.
All the latest from manager news conferences as Pep Guardiola and Mikel Arteta speak before the EFL Cup final plus Premier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results